Vir Biotechnology (VIR) Financials

$11.39

$-0.07 (-0.57%)

As on 04-Sep-2026 18:39EDT

Market cap

$1,927 Mln

Revenue (TTM)

$303 Mln

P/E Ratio

--

P/B Ratio

2

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	303.23	68.56	74.21	86.18	1,615.80	1,095.42
Cost of Revenue	-212.30	11.71	478.65	572.83	620.97	513.87
Gross Profit	515.53	56.85	-404.44	-486.65	994.83	581.54
Operating Expenses	785.29	524.87	182.73	197.66	161.76	160.79
Operating Profit (EBIT)	-269.77	-468.02	-587.17	-684.31	833.07	420.75
Other Income	--	--	--	--	--	129.05
Profit before Tax	-251.30	-437.77	-523.11	-628.19	754.28	549.80
Provision for Tax	0.38	0.22	-1.15	-13.08	238.44	21.22
Profit after Tax (Net Income)	-251.68	-437.99	-521.96	-615.06	515.84	528.58
Minority Interest	--	--	--	0.06	--	--
Consolidated Profit	--	--	--	--	515.84	528.58

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	982.49	765.28	1,150.39	1,590.24	2,077.96	1,431.85
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	137.35	144.73	128.77	153.42	213.10	181.18
Current Liabilities	94.96	92.82	119.66	175.41	511.03	341.24
Total Liabilities	1,309.77	1,002.82	1,398.81	1,919.06	2,802.09	1,954.27

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	641.07	488.74	356.33	330.83	283.01	391.45
Current Assets	573.74	514.08	1,042.46	1,588.23	2,519.08	1,562.82
Total Assets	1,309.77	1,002.82	1,398.81	1,919.06	2,802.09	1,954.27
Total Debt*	93.27	186.91	97.89	124.54	127.97	137.49
Net Current Assets	478.78	421.27	922.80	1,412.82	2,008.05	1,221.58

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-391.78	-446.35	-778.79	1,663.25	-47.59
Cash Flow from Investing Activities	--	310.37	499.37	164.73	-1,193.46	-140.81
Cash from Financing Activities	--	3.79	4.39	7.38	34.76	100.33
Net Cash Inflow / Outflow	--	--	--	--	--	-88.07

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-1.86	-3.15	-3.82	-4.57	3.87	3.95
Cash EPS ($)	--	-3.06	-3.71	-4.44	3.92	3.99
Adjusted Book Value ($)	--	5.50	8.41	11.81	15.61	10.70
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-2.81	-3.26	-5.79	12.49	-0.36
Free Cash Flow per Share ($)	--	-2.85	-3.32	-5.95	11.98	-0.52

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-39.81	-35.23	-31.37	27.33	44.86
ROE (%)	-28.80	-45.73	-38.09	-33.53	29.39	49.20
ROA (%)	-19.31	-36.47	-31.46	-26.06	21.69	36.80
EBIT Margin (%)	-84.40	-638.56	-705.44	-767.10	46.68	50.19
Net Margin (%)	-83.00	-638.87	-703.40	-713.69	31.92	43.17
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	1,495.93	-0.08	-0.14	-0.95	0.48	13.34
EBIT Growth (%)	55.79	16.37	20.82	-187.64	37.19	284.05
Net Profit Growth (%)	54.26	16.09	15.14	-219.24	-2.41	276.98
EPS Growth (%)	53.58	0.18	0.17	-2.18	-0.02	2.68
Book Value Growth (%)	-14.99	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-1.92	-1.92	-2.20	6.53	10.60
Price / Book Value	1.97	1.10	0.87	0.85	1.62	3.91
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	1.20	-1.32	-0.39	0.07	1.44	9.06
Close Price ($)	10.19	6.03	7.34	10.06	25.31	41.87
High Price ($)	11.50	14.45	13.09	31.55	42.54	141.01
Low Price ($)	4.16	4.16	6.56	7.72	18.05	25.31
Market Cap ($ Cr)	1,926.52	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.24	0.09	0.08	0.06	0.10
Short term debt to equity ratio	0.01	0.01	0.01	0.01	0.00	0.00
Current Ratio	6.04	5.54	8.71	9.05	4.93	4.58
Quick Ratio	6.04	--	--	--	--	4.55
Interest Coverage	--	--	--	--	4.12	2.01

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	7.22	5.25	6.87	13.46	1.63	70.57
Asset Turnover	0.23	0.06	0.04	0.04	0.68	0.76
Receivable days	--	23.18	41.10	80.53	90.36	129.20
Inventory Days	--	--	--	--	5.05	6.11
Payable days	--	232.20	4.36	4.07	3.81	4.12
Cash Conversion Cycle	--	--	--	--	91.61	131.19

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.